ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
CytokineRelease
|
35 |
9.6K |
1 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
35
|
9.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
CytokineRelease
|
35 |
9.6K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
9.6K
|
1
|
|
ASX - By Stock
|
KCN |
Re:
BUYBACKS ROSS - with every last cent, close the VIP door for good
|
|
CytokineRelease
|
841 |
403K |
0 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
841
|
403K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
CytokineRelease
|
317 |
140K |
1 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
317
|
140K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Extends Vega Zone with Standout Intercepts
|
|
CytokineRelease
|
62 |
30K |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
62
|
30K
|
6
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Extends Vega Zone with Standout Intercepts
|
|
CytokineRelease
|
62 |
30K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
62
|
30K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
CytokineRelease
|
131 |
54K |
0 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
131
|
54K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
CytokineRelease
|
131 |
54K |
0 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
131
|
54K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
CytokineRelease
|
131 |
54K |
2 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
131
|
54K
|
2
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Extends Vega Zone with Standout Intercepts
|
|
CytokineRelease
|
62 |
30K |
2 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
62
|
30K
|
2
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Extends Vega Zone with Standout Intercepts
|
|
CytokineRelease
|
62 |
30K |
1 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
62
|
30K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Extends Vega Zone with Standout Intercepts
|
|
CytokineRelease
|
62 |
30K |
7 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
62
|
30K
|
7
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Expands High-Grade Vega Zone at CV13
|
|
CytokineRelease
|
101 |
35K |
5 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
101
|
35K
|
5
|
|
ASX - By Stock
|
PMT |
Re:
PMT Megathread
|
|
CytokineRelease
|
1.7K |
682K |
10 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
1.7K
|
682K
|
10
|
|
ASX - By Stock
|
PMT |
Re:
PMT Megathread
|
|
CytokineRelease
|
1.7K |
682K |
1 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
1.7K
|
682K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Guess BLA submission date
|
|
CytokineRelease
|
2 |
1.1K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
PMT |
Re:
PMT Megathread
|
|
CytokineRelease
|
1.7K |
682K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
1.7K
|
682K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Aims Up To $4.17 Bln Valuation In US IPO
|
|
CytokineRelease
|
112 |
45K |
0 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
112
|
45K
|
0
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Announces C$75M Flow-Through Financing
|
|
CytokineRelease
|
27 |
10K |
1 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Patriot Announces C$75M Flow-Through Financing
|
|
CytokineRelease
|
27 |
10K |
3 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
27
|
10K
|
3
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Trading Halt
|
|
CytokineRelease
|
99 |
42K |
0 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
99
|
42K
|
0
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Trading Halt
|
|
CytokineRelease
|
99 |
42K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
99
|
42K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Trading Halt
|
|
CytokineRelease
|
99 |
42K |
2 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
99
|
42K
|
2
|
|
ASX - By Stock
|
PMT |
Re:
Ann: 122.5m at 1.42% Li2O and 71.4m at 1.57% Li2O at CV5
|
|
CytokineRelease
|
48 |
15K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
48
|
15K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: New High-Grade Zone Discovered at CV13 - 34.4m @ 2.90% Li2O
|
|
CytokineRelease
|
132 |
36K |
6 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
132
|
36K
|
6
|
|
ASX - By Stock
|
PMT |
Re:
Ann: New High-Grade Zone Discovered at CV13 - 34.4m @ 2.90% Li2O
|
|
CytokineRelease
|
132 |
36K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
132
|
36K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: New High-Grade Zone Discovered at CV13 - 34.4m @ 2.90% Li2O
|
|
CytokineRelease
|
132 |
36K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
132
|
36K
|
4
|
|
ASX - By Stock
|
PMT |
Re:
Ann: New High-Grade Zone Discovered at CV13 - 34.4m @ 2.90% Li2O
|
|
CytokineRelease
|
132 |
36K |
6 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
132
|
36K
|
6
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
192
|
51K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
192
|
51K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
PMT Megathread
|
|
CytokineRelease
|
1.7K |
682K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1.7K
|
682K
|
0
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 CV5 Drill Hole Results incl 133.9m @ 1.21% Li2O
|
|
CytokineRelease
|
51 |
12K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
51
|
12K
|
0
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 CV5 Drill Hole Results incl 133.9m @ 1.21% Li2O
|
|
CytokineRelease
|
51 |
12K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
51
|
12K
|
3
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
192
|
51K
|
1
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
192
|
51K
|
0
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
192
|
51K
|
5
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
192
|
51K
|
4
|
|
ASX - By Stock
|
PMT |
Re:
Ann: Final 2023 Drill Hole Results for the CV13 & CV9 Pegmatites
|
|
CytokineRelease
|
192 |
51K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
192
|
51K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
CytokineRelease
|
116 |
44K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
116
|
44K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
CytokineRelease
|
675 |
304K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
675
|
304K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
CytokineRelease
|
943 |
406K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
943
|
406K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
CytokineRelease
|
102 |
22K |
6 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
102
|
22K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Share Cafe Webinar - Potency assay data was in place for GvHD trial
|
|
CytokineRelease
|
15 |
4.7K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
15
|
4.7K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
CytokineRelease
|
549 |
185K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
185K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB shareholder class action
|
|
CytokineRelease
|
116 |
44K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
116
|
44K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
AA
|
|
CytokineRelease
|
13 |
4.9K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
13
|
4.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
CytokineRelease
|
5.7K |
2.8M |
1 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
5.7K
|
2.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
CytokineRelease
|
10K |
3.3M |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
10K
|
3.3M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
CytokineRelease
|
10K |
3.3M |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
10K
|
3.3M
|
1
|
|
ASX - By Stock
|
PMT |
Re:
PMT Megathread
|
|
CytokineRelease
|
1.7K |
682K |
9 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
1.7K
|
682K
|
9
|
|